改善艾滋病毒成人的重症监护室入院后的一年死亡率:一项20年观察性研究
Tanmay Kanitkar1,2, Nicholas Bakewell3, Oshani Dissanayake2
1Intensive Care Unit, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.
Journal of intensive care medicine
|April 2, 2024
概括
艾滋病毒感染者进入重症监护室后的一年死亡率有所下降. 医院出院后继续参与护理对于改善这一群体的结果至关重要.
科学领域:
- 临界护理医学 临界护理医学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 艾滋病毒感染者 (PWH) 面临更高的重症监护室 (ICU) 入院和死亡风险.
- 对于PWH在医院出院后的死亡率模式尚不清楚.
- 本研究检查了PWH的ICU入院后1年死亡率的趋势.
研究的目的:
- 描述艾滋病毒成年人的ICU入院后1年死亡率的趋势.
- 分析与这组患者死亡风险相关的因素.
- 为了评估20年死亡率的变化.
主要方法:
- 在2000-2019年期间被录入ICU的成年PWH的回顾性分析.
- 从ICU入院之日起的一年死亡率的计算.
- 根据患者特征和日历年份进行调整的考克斯回归分析.
主要成果:
- 总共有221名PWH被送入ICU,一年死亡率为50%.
- 经过调整后,1年死亡率的风险每年下降7%.
- 在活出ICU的患者中也观察到类似的趋势.
结论:
- 在艾滋病毒感染者中,接受ICU治疗后的一年死亡率有所下降.
- 需要多中心研究来证实这些发现.
- 强调持续的艾滋病毒护理在住院后的重要性.
关键词:
艾滋病 艾滋病 艾滋病是什么?亚太地区的亚太地区II.CD4+ T 细胞计数 CD4+ T 细胞计数艾滋病病毒 艾滋病病毒 艾滋病病毒抗逆转录病毒药物治疗重症监护室的重症监护室是重症监护室的重症监护室.重症监护病房的重症监护病房是一个重症监护病房.死亡率 死亡率结果结果结果结果.感染艾滋病毒的人.幸存率 幸存率 生存率病毒载量 病毒载量更多相关视频
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.3K
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
16.6K
相关概念视频
Retrovirus Life Cycles
45.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.9K
Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Acute Respiratory Failure-V
137
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
137
Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
